Daniel Derocco

Daniel DeRocco currently serves as Executive Director of Financial Planning and Analysis at UroGen Pharma, a position held since December 2021, after previously serving as Sr. Director of Financial Planning and Analysis. Prior experience includes roles at Amarin Corporation, Aralez Pharmaceuticals Inc., IKARIA, Inc., New American Therapeutics, Inc., Akrimax Pharmaceuticals, LLC, and Reliant Pharmaceuticals, where responsibilities ranged from senior finance roles to financial analysis. Daniel began a career in finance at Ernst & Young, progressing from Staff Auditor to Senior Auditor. Daniel holds a degree from Villanova University, completed in 1999.